Recombinant Human Promotilin/MLN Protein，His & GST

Promotilin, also known as MLN (motilin-like neuropeptide), is a peptide hormone primarily produced in the gastrointestinal tract, playing a crucial role in regulating gut motility. Its discovery stems from the need to understand gastrointestinal disorders, particularly those associated with motility dysfunction, such as gastroparesis and irritable bowel syndrome. Research has shown that promotilin stimulates gastric contractions and promotes coordinated motor activity in the digestive system, acting through specific receptors in the gastrointestinal tract. The recombinant production of promotilin has garnered significant attention in biomedical research, as it offers a tool for studying its physiological effects and potential therapeutic applications. By utilizing recombinant protein technology, researchers are able to produce pure and active forms of promotilin, allowing for detailed investigations into its biological functions and mechanisms of action. Furthermore, understanding the signaling pathways activated by promotilin could lead to new treatment strategies for motility-related disorders, enhancing the quality of life for affected patients. As studies continue to explore the pharmacological potential of this peptide, both in vitro and in vivo, the promise of recombinant promotilin as a therapeutic agent remains an exciting area of investigation in gastrointestinal research.